Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

Clinical trial NCT06873516 · COMPLETED

Trial details

NCT number: NCT06873516
Sponsor: Evommune, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria

Start date: 2025-03-20
Primary completion: 2026-05-29
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.